Expertise in
18
conditions

Dr. Andrew N. Dauber

Pediatric Endocrinology | Pediatrics
3333 Burnet Ave, 
Cincinnati, OH 
Accepting New Patients
Expertise in
18
conditions
3333 Burnet Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Andrew Dauber is a Pediatric Endocrinologist and a Pediatrics provider in Cincinnati, Ohio. Dr. Dauber is highly rated in 18 conditions, according to our data. His top areas of expertise are Short Stature (Growth Disorders), Precocious Puberty, Growth Hormone Deficiency (GHD), and Idiopathic Short Stature (ISS). Dr. Dauber is currently accepting new patients.

His clinical research consists of co-authoring 126 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Endocrinology
Pediatrics
Licenses
Pediatrics in MA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 8 Less Insurance Carriers -

Locations

3333 Burnet Ave, Cincinnati, OH 45229

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
Enrollment Status: Completed
Publish Date: July 20, 2025
Intervention Type: Drug
Study Drugs: MOD-4023, Somatropin
Study Phase: Phase 3
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drugs: LUM-201, rhGH Norditropin® pen
Study Phase: Phase 2
Clinical Characterization and Trial of Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency
Clinical Characterization and Trial of Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency
Enrollment Status: Completed
Publish Date: July 30, 2024
Intervention Type: Drug
Study Drug: Norditropin
Study Phase: Phase 1/Phase 2
Treatment With Recombinant Human Insulin-like Growth Factor 1 (rhIGF-1) in Patients With Pappalysin-2 (PAPP-A2) Gene Mutation.
Treatment With Recombinant Human Insulin-like Growth Factor 1 (rhIGF-1) in Patients With Pappalysin-2 (PAPP-A2) Gene Mutation.
Enrollment Status: Completed
Publish Date: February 28, 2024
Intervention Type: Drug
Study Drug: Increlex
Study Phase: Phase 1/Phase 2
A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drug: Dulaglutide
Study Phase: Phase 3
Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age
Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age
Enrollment Status: Completed
Publish Date: August 09, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

126 Total Publications

Incorporating Rare Disease Growth Monitoring Into Routine Practice to Improve Early Recognition and Diagnosis of Genetic Conditions.
Incorporating Rare Disease Growth Monitoring Into Routine Practice to Improve Early Recognition and Diagnosis of Genetic Conditions.
Journal: Pediatric annals
Published: September 09, 2025
Similar Doctors
Expertise in
8
conditions
Dr. Philippe F. Backeljauw
Pediatric Endocrinology | Pediatrics
Expertise in
8
conditions
Dr. Philippe F. Backeljauw
Pediatric Endocrinology | Pediatrics
3333 Burnet Ave, Ml 7012, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4744
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients

Philippe Backeljauw is a Pediatric Endocrinologist and a Pediatrics provider in Cincinnati, Ohio. Dr. Backeljauw is highly rated in 8 conditions, according to our data. His top areas of expertise are Turner Syndrome, Intersex, Growth Hormone Deficiency (GHD), Pediatric Growth Hormone Deficiency, and Hormone Replacement Therapy (HRT). Dr. Backeljauw is currently accepting new patients.

Expertise in
20
conditions
Dr. Iris Gutmark
Pediatric Endocrinology
Expertise in
20
conditions
Dr. Iris Gutmark
Pediatric Endocrinology
3333 Burnet Ave., Ml 7012, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4744
Languages Spoken:
English
See accepted insurances

Iris Gutmark is a Pediatric Endocrinologist in Cincinnati, Ohio. Dr. Gutmark is highly rated in 20 conditions, according to our data. Her top areas of expertise are Turner Syndrome, Intersex, Neurohypophyseal Diabetes Insipidus, Diabetes Insipidus (DI), and Hormone Replacement Therapy (HRT).

Expertise in
12
conditions
Dr. Lawrence M. Dolan
Pediatric Endocrinology
Expertise in
12
conditions
Dr. Lawrence M. Dolan
Pediatric Endocrinology
3333 Burnet Ave, Ml 7012, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4744
Languages Spoken:
English
See accepted insurances

Lawrence Dolan is a Pediatric Endocrinologist in Cincinnati, Ohio. Dr. Dolan is highly rated in 12 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Obesity, Congenital Hyperinsulinism, and Gastric Bypass.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dauber's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 47 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile